n (%) | |
---|---|
Co-trimoxazole (CPT) prophylaxis | 76 (89.4%) |
ART initiation | 58 (68.2%) |
Timing of ART initiation (days_median [IQR]) | 54.5 [21.8-114.0] |
- During TB treatment (0–180 days) | 48 (82.8%) |
Initiation phase (0–60 days) | 33 (68.8%) |
Continuous phase (61-180 days) | 15 (31.2%) |
- After anti-TB treatment (> 180 days) | 10 (17.2%) |
ART regimen including Nevirapine (NVP) during TB treatment | 12 (22.6%)* |
TB information is recorded on ART patient’s record | 59 (70.2%) |